Biodesix's Series F Round

Biodesix raised a round of funding on February 12, 2016.

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat, a serum proteo…

Articles about Biodesix's Series F Round: